CD103+CD8+ tissue-resident memory T cell infiltration predicts clinical outcome and adjuvant therapeutic benefit in muscle-invasive bladder cancer-Reference-Cited by-同舟云学术

CD103+CD8+ tissue-resident memory T cell infiltration predicts clinical outcome and adjuvant therapeutic benefit in muscle-invasive bladder cancer

Published:2022-02-14 Issue:11 Volume:126 Page:1581-1588
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Jin Kaifeng^ORCID,Yu Yanze,Zeng Han,Liu Zhaopei^ORCID,You Runze,Zhang Hongyi,Liu Chunnan,Su Xiaohe,Yan Sen,Chang Yuan,Xu Le,Xu Jiejie^ORCID,Zhu Yu^ORCID,Wang Zewei^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-022-01725-6.pdf

Reference36 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

2. Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70:404–23.

3. Gide TN, Quek C, Menzies AM, Tasker AT, Shang P, Holst J, et al. Distinct immune cell populations define response to anti-PD-1 monotherapy and anti-PD-1/anti-CTLA-4 combined therapy. Cancer Cell. 2019;35:238.e6–55.e6.

4. Fridman WH, Zitvogel L, Sautes-Fridman C, Kroemer G. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 2017;14:717–34.

5. Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ. Natural innate and adaptive immunity to cancer. Annu Rev Immunol. 2011;29:235–71.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multilayered Immunity by Tissue-Resident Lymphocytes in Cancer;Annual Review of Immunology;2024-06-28

2. Tissue-Resident Memory T Cells in Gastrointestinal Cancers: Prognostic Significance and Therapeutic Implications;Biomedicines;2024-06-17

3. RAD51 Expression as a Biomarker to Predict Efficacy of Platinum-Based Chemotherapy and PD-L1 Blockade for Muscle-Invasive Bladder Cancer;Journal of Immunotherapy;2024-05-27

4. Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors;OncoImmunology;2024-05-10

5. TDO2 promotes bladder cancer progression via AhR-mediated SPARC/FILIP1L signaling;Biochemical Pharmacology;2024-05